U.S., Nov. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07917260) titled 'Assessing Blood Pressure Variability in a Healthy Adult Population During Transcutaneous Hypoglossal Nerve Stimulation With the Zeus Sleep Device' on Sept. 25.
Brief Summary: Transcutaneous hypoglossal nerve stimulation is an emerging treatment option for Obstructive Sleep Apnoea (OSA), a sleep condition where breathing is repeatedly limited. The standard treatment for OSA is not always well tolerated therefore, more alternatives are needed.
Transcutaneous hypoglossal nerve stimulation uses a device, such as Zeus, which sticks underneath the chin to deliver electrical pulses during sleep. These pulses stimulate the hypoglossal nerve...